Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
CEMPRA, INC. (MLNT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/25/2019 |
3
| Lococo Ryan (COO) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 10/25/2019 |
3
| Blum Susan (VP of Finance & CAO) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 09/13/2019 |
3
| Sanfilippo Jennifer A (interim Chief Executive Office) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 07/02/2019 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Sold 13,000 shares
@ $5.5724, valued at
$72.4k
|
|
| 06/26/2019 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Exercised 50,000 options to buy
@ $0 |
|
| 06/12/2019 |
4
| Ferro Kevin (10% Owner) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 06/12/2019 |
4
| DOWNEY BRUCE (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 06/12/2019 |
4
| GILL DAVID N (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 06/12/2019 |
4
| ZACCARDELLI DAVID (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 06/12/2019 |
4
| Koestler Thomas P (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 06/12/2019 |
4
| Galeota James JR (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 05/20/2019 |
4
| Cammarata Sue (Chief Medical Officer) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 120,000 restricted stock units
@ $0 |
|
| 05/20/2019 |
4
| Milligan Peter J (CFO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
| 02/26/2019 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 400,000 restricted stock units
@ $0 |
|
| 02/26/2019 |
4
| Vatera Healthcare Partners LLC (10% Owner) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Bought 9,375,000 options to buy
@ $8, valued at
$75M
|
|
| 01/11/2019 |
3
| Vatera Capital Management LLC (10% Owner) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 12/03/2018 |
4
| DOWNEY BRUCE (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $2.12, valued at
$53k
|
|
| 11/09/2018 |
3
| DOWNEY BRUCE (Director) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 10/29/2018 |
4
| JOHNSON JOHN (Interim CEO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 150,000 options to buy
@ $2.8, valued at
$420k
Granted 50,000 restricted stock units
@ $0 |
|
| 09/25/2018 |
4
| Milligan Peter J (CFO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 370,000 options to buy
@ $4.5, valued at
$1.7M
|
|
| 09/25/2018 |
3
| Milligan Peter J (CFO) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 06/14/2018 |
4
| Koestler Thomas P (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/14/2018 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/14/2018 |
4
| GONZALO CECILIA (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/14/2018 |
4
| Ferro Kevin (10% Owner) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/14/2018 |
4
| ZACCARDELLI DAVID (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/14/2018 |
4
| GILL DAVID N (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/14/2018 |
4
| Cammarata Sue (Chief Medical Officer) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 80,000 options to buy
@ $7.45, valued at
$596k
|
|
| 06/14/2018 |
4
| Kong Garheng (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/14/2018 |
4
| Galeota James JR (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/14/2018 |
4
| Duffy Erin (Chief Scientific Officer) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 38,000 options to buy
@ $7.45, valued at
$283.1k
|
|
| 06/14/2018 |
4
| Estrem Paul (CFO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 76,000 options to buy
@ $7.45, valued at
$566.2k
|
|
| 06/14/2018 |
4
| Wechsler Daniel Mark (See Remarks) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 150,000 options to buy
@ $7.45, valued at
$1.1M
|
|
| 05/31/2018 |
4
| Estrem Paul (CFO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Bought 10,000 shares
@ $5, valued at
$50k
|
|
|
|
|